In February 2026, Ameriprise Financial (AMP) experienced considerable insider selling activity, with several top executives divesting significant portions of their holdings. These transactions, valued at millions of dollars, suggest a notable shift in the personal investment strategies of the company's leadership. This series of sales has drawn attention from market analysts, prompting discussions about the implications for Ameriprise's stock performance and investor sentiment.
Ameriprise Financial, a leader in wealth management and financial planning established in 1894, operates primarily through its Advice & Wealth Management and Asset Management (Columbia Threadneedle) divisions. Headquartered in Minnesota, the firm plays a crucial role in guiding individuals and institutions through complex financial landscapes. The recent insider share liquidations occurred across several key leadership positions, indicating a broad trend rather than isolated incidents.
On February 12, 2026, William Truscott, the CEO of Global Asset Management, executed a sale of 5,000 shares of AMP stock. This transaction, valued at approximately $2,660,400, resulted in a substantial 22% reduction in his overall ownership of the company. Just one day prior, on February 11, Gumer Alvero, the PRESIDENT-INSURANCE & ANNUITIES, also disclosed a sale, divesting 4,658 shares for a total of $2,528,735.
The largest of these insider sales took place on February 6, 2026, when James Cracchiolo, the Chairman & CEO of Ameriprise Financial, sold a massive block of 48,813 shares. This single transaction was valued at approximately $26,600,964, making it the most significant sale among the reported activities. Despite these substantial insider sell-offs, CNN reported that seven analysts maintain a 'Buy' rating on the stock, with a consensus one-year average price target of $580 from 14 analysts, suggesting that professional outlooks remain largely positive.
The extensive insider selling at Ameriprise Financial in early 2026, involving multiple high-ranking executives and millions of dollars in stock, provides a compelling look into the internal dynamics of the company's leadership's investment decisions. While the reasons for these individual sales are not explicitly stated, the cumulative effect raises questions about future stock performance and market perception, even as external analysts maintain a favorable outlook for the financial giant.